Page 34 - Terminology-Clinical-Research
P. 34

have been assigned which interventions. Types of Masking   two months – which is not a true reflection of the benefit.
        include Open label, Single blind masking, and Double blind  Similarly, if a trial had, for example, 800 patients, the
        masking.                                               median would be reached once 400 reached the endpoint
                                                               (e.g. experienced a particular event). But the other 400 may
        Matched-pair design: A type of parallel trial design in   potentially do much better, and the median value would not
        which investigators identify pairs of subjects who are   reflect this.
        “identical” with respect to relevant factors, then randomize
        them so that one receives Treatment A and the other    Medical condition in easily understood language: A
        Treatment B.                                           description of the medical condition being studied in non-
                                                               medical language.
        Matching: See Pairing.
                                                               Medical condition(s) investigated: Description of
        Mean: The sum of the values of all observations or     intended indication for the product under development.
        data points divided by the number of observations; an
        arithmetical average.                                  Medical condition: The disease or a description of the
                                                               intended indication that is being investigated in the clinical
        Mean difference (in meta-analysis): A method used to   trial.
        combine measures on continuous scales (e.g., weight),
        where the mean, standard deviation and sample size in   Medical device: An intervention defined as: 1. Used for
        each group is known. The weight given to the difference   diagnosis, cure, mitigation, treatment or prevention of a
        in means from each study (e.g., how much influence each   disease or condition. 2. Affects the structure and function
        study has on the overall results of the meta - analysis) is   of the body. 3. Does not achieve intended use through
        determined by the precision of its estimate of effect.  chemical reaction. 4. Is not metabolized.

        Median: The middle value in a data set; that is, just as   Medical monitor: A sponsor representative who has
        many values are greater than the median and lower than   medical authority for the evaluation of the safety aspects of
        the median value. (With an even number of values, the   a clinical trial.
        conventional median is halfway between the two middle
        values).                                               Medical product: See Intervention.

        MedDRA Classification: Medical Dictionary for          Medicinal product: Synonym for therapeutic intervention,
        Regulatory Activities - is a medical terminology used to   but usually a drug.
        classify adverse event information associated with the use   Medicines and Healthcare products Regulatory Agency
        of biopharmaceuticals and other medical products (e.g.,
        medical devices and vaccines).                         (MHRA): The UK government agency responsible for
                                                               ensuring that medicines and medical devices work, and are
        MedDRA Level: Key to MedDRA hierarchical levels        acceptably safe.
        (highest to lowest) SOC (System Organ Class) HLGT      Mega-trials: Massive trials that test the advantages of
        (High Level Group Term) HLT (High Level Term) PT
        (Preferred Term) LLT (Lowest Level Term).              therapeutic interventions by enrolling 10,000 or more
                                                               subjects. Synonym: large sample trials.
        Median: Is the middle value in a set of numbers when
        they are all placed in order from smallest to largest, e.g.   Memorandum of Understanding (MOU): A formal
                                                               agreement between the Food and Drug Administration
        the median of 5,7,9,10,13,18,23 is 10. In a clinical trial, the   (FDA) and federal, state, or local government agencies;
        median is reached when 50% of patients have experienced
        an event (such as death or recurrence). The median     academic institutions; and other entities. Note: The MOU
        figure for an endpoint is normally noted with a small   constitutes an understanding between the parties but is
        ‘m’ e.g. mPFS (median progression free-survival). Note:   a nonbinding agreement. It is FDA’s policy to enter into
                                                               MOUs with other entities whenever there is a need to
        It is important to remember that taking a median value   define lines of authority or responsibility, or to clarify
        for survival may not always provide the most accurate
        picture of the effects of a treatment. For example, if 51%   cooperative procedures.
        of patients gain only two months or less survival benefit   Messages (HL7): The atomic unit of data transferred
        from a treatment while 49% gain 10 months or more, the   between systems. It comprises a group of segments in a
        median survival would, in fact, be calculated as less than   defined sequence. Each message has a message type that



         34                                          AlphaScienceLabs.com
   29   30   31   32   33   34   35   36   37   38   39